Brief: Seres Therapeutics Q1 EPS USD -0.27
08/05/2024 12:00
May 08 (Reuters) - Seres Therapeutics Q1 net income USD -40.133 million. * Q1 operating expenses USD 39.586 million * Q1 operating income USD -39.586 million
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47